Autopsy report · NCT06219681
Modulating Repetitive Negative Thinking Related Brain Networks in Young Adults With Depression
Cause of deathStaffing, sites or logistics
“Terminated due to PI resignation. Not related to safety, efficacy, or administrative mandate.”
Life of this trial
- Ran for about 1 year 3 months before it stopped.
- 54 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Laureate Institute for Brain Research, Inc.
- Sponsor type
- University, hospital or other
- Conditions
- Depressive Disorder, Major
- Interventions
- Active neurofeedback; Sham neurofeedback
- Participants
- 54
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
“terminated due to administrative reasons.” - Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
“Terminated due to safety concerns.” - Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
“Terminated due to loss of funding and former PI left the institution” - Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer
“Terminated due to lack of efficacy” - Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma
“Terminated prematurely for administrative reasons not related to patient safety.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.